Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder

Not Applicable

• Conditions: -F31; F31

• Registration Number: PER-105-06
• Lead Sponsor: OVARTIS BIOSCIENSES PERU S.A.,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-01-31
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Written informed consent provided prior to participation in the extension study
2. Successful completion of the CLIC477D2303 study.
3. Cooperation and willingness to comply with all the requirements of the study.

Exclusion Criteria

1. Premature discontinuation of the CLIC477D2303 study.
2. Failure to comply with study CL1C477D2303.

Study & Design

• Study Type: Interventional
• Study Design: Not specified